Major Updates to Medicare Plan Finder for 2026
The Centers for Medicare & Medicaid Services (CMS) has announced significant enhancements to Medicare Plan Finder (MPF) and Medicare.gov starting in Contract Year (CY) 2026. These changes are designed to […]
CMS Announces Medicare Advantage and Part D Proposed Rule for CY 2026: Key Impacts for Brokers and TPMOs
The Centers for Medicare & Medicaid Services (CMS) has announced the proposed rule for Contract Year (CY) 2026 affecting Medicare Advantage (MA) and Medicare Part D programs. These updates aim […]
CMS Issues New MBIs to Beneficiaries: What Brokers Need to Know
The Centers for Medicare and Medicaid Services (CMS) has started issuing new Medicare Beneficiary Identifiers (MBIs) to about 1.2 million beneficiaries. This update addresses specific cases where MBIs were compromised […]
Changes to Medicare in 2025 Affect Dual Eligible Special Needs Plans (D-SNPs)
Key Takeaways for Brokers The Centers for Medicare & Medicaid Services (CMS) has released the Medicare Final Rule for 2025, which includes significant changes that will impact Dual Eligible Special […]
Prescription Drug Plan (PDP) Compensation Updates
As 2025 approaches, significant changes are on the horizon for Prescription Drug Plans (PDPs), largely driven by the Inflation Reduction Act (IRA). These changes include the elimination of the Coverage Gap (or “donut hole”), a new $2,000 out-of-pocket spending cap, and adjustments in cost-sharing responsibilities during the catastrophic coverage phase.
In light of these shifts, Wellcare has made the difficult decision to cease new and renewal commissions for their PDP products starting January 1, 2025. Meanwhile, Aetna’s SilverScript Choice PDP will be offered as a non-commissionable product nationwide, with renewal commissions continuing on existing commissionable business.
Stay informed and prepared as these updates will impact your approach to PDP offerings in the upcoming year.
WellCare: Transitioning from Medicare Supplement to Medicare Advantage Crossover Training
Wellcare’s Business Acumen – Selling Against Medicare Supplement Join us as we dive into key topics:🔹 Annual price increases for PDP and Medicare Supplement🔹 The growing low-income population and its […]
CMS Announces 2025 Part D Bid & Premium Stabilization Demonstration Program
The Centers for Medicare & Medicaid Services (CMS) recently announced some exciting developments for Medicare Part D. On July 29, 2024, alongside preliminary 2025 Medicare Part D bid information, CMS […]
Important Update from CMS! Is Employer sponsored health insurance coverage still creditable in 2025?
CMS recently released the Final Calendar Year (CY) 2025 Part D Redesign Program Instructions that provides guidance regarding the implementation of section 11201 of the Inflation Reduction Act of 2022 […]
CMS’ 2025 Proposed Rule – Agent Commissions
The Centers for Medicare & Medicaid Services (CMS) annually releases a memorandum that sets the stage for the healthcare industry by establishing the maximum Fair Market Value (FMV) for Agent […]
The Centers for Medicare & Medicaid Services (CMS) revealed on Thursday, August 31st 2023, that the initial group of ten Medicare Part D medications slated for negotiation under the Inflation Reduction Act (IRA) has been identified.
These drugs have been designated based on the outlined criteria within the IRA. This legislation mandates that CMS prioritize drugs with the highest Medicare expenditure and minimal competition, among other […]